Weekly Recap | ARKG.US +13.35%, AI healthcare leads genomics themeWeekly Review·Sep 19 at 07:15 AMARKG+0.33%
Weekly Recap | Twist Bioscience +31.26%, signs deal with Lilly TuneLabWeekly Review·Sep 19 at 06:54 AMTWST-0.69%
Weekly Recap | Medicinova +83.43%, most brokers rate it buyWeekly Review·Sep 19 at 06:26 AMMNOV-0.60%
Weekly Recap | Alnylam Pharma -3.67%, consensus target above spotWeekly Review·Sep 19 at 05:31 AMALNY+1.99%
Trump: Accelerate access to research on psychedelic drugsWallstreetcn·Apr 18 at 01:14 PMGHRS-1.17%MNMD0.00%
The Nasdaq Biotechnology Index once fell over 1%. Among the constituent stocks, Prime Medicine dropped 9.76%, Alpha Teknova fell 9.46%, Corvus Pharmaceuticals decreased 8.29%, and Sarepta Therapeutics declined 6.67%. Compass Pathways rose 6.52%, Applied Therapeutics increased 6.12%, Adaptive Biotechnologies grew 8.36%, and Lexicon Pharma (LXRX) surged 15.80%Wallstreetcn·Jun 25, 2025 at 04:22 PMCMPS-1.18%ADPT-2.62%
